University of Colorado Advanced Reproductive Medicine specializes in the evaluation and treatment of infertility and reproductive disorders. The center offers each patient a comprehensive evaluation and treatment plan to provide personalized care with the most advanced technology available. Our goal is to make every effort to treat reproductive disorders with simple methods and less expensive therapies. However, in cases where these prove unsuccessful, as a state of the art facility, Advanced Reproductive Medicine draws upon the latest advances and the most sophisticated methods available in infertility and reproductive therapy
The team is made up of nine physicians – Drs. Zane Al-Safi, Ruben Alvero, Serena Dovey, Laxmi Kondapalli, Shona Murray, Alex Polotsky, Lauren Roth, Nanette Santoro and Sahar Stephens – who are board certified both in obstetrics and gynecology and the subspecialty of reproductive endocrinology and infertility, and one physician – Dr. Randall Meacham – who is subspecialty trained in male infertility. This team approach of both female and male infertility specialists offers the most comprehensive care for the treatment of infertility in one centralized location.
University of Colorado Advanced Reproductive Medicine is currently involved with numerous studies show-casing efforts in oncology-fertility, the preservation of human fertility during cancer treatments, and new contraceptive options.
This study is looking at a new contraceptive patch which will offer women a contraceptive option that contains no estrogen, using a proven medication called Levonorgestrel.
This study, sponsored by the Oncofertiltiy Consortium, studies the removal and preservation of women’s ovarian tissue prior to chemotherapy. Early studies have shown that removed ovarian tissue remain functional after cancer treatments, and can be reinserted into a woman’s pelvis area without surgery, causing ovulation, and thus resulting in pregnancy.
This is a follow-up study to the department’s recent successful study in the area of oncology-fertility, known in the medical field as “oncofertility.” The ROVER study will demonstrate the importance and increased need of oocyte preservation for women undergoing cancer treatment who wish to preserve eggs prior to treatment, as well as for personal or age reasons. This study intends to make oocyte preservation – a relatively new option – available to all women.
AMGIOS (Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation) compares clomiphene citrate, Letrozole, and gonodatropin fertility treatments for women with unexplained infertility.
PPCOS II (Pregnancy in polycystic ovary syndrome II) is a 20-week, double-blind, randomized trial of clomiphene citrate and Letrozole for the treatment of infertility in women with polycystic ovary syndrome.
Thank you for your interest in University of Colorado Advanced Reproductive Medicine.
The newsroom is a comprehensive online resource for the media. Here you’ll find the latest news coverage on Advanced Reproductive Medicine, as well as fact sheets, patient stories and recent press releases.
The medical team at Advanced Reproductive Medicine is an expert source on the latest infertility research and information. Feel free to contact us for interviews or further assistance. Photos are available.
Send an Email
…and stay up-to-date on the latest fertility and reproductive medicine news.